ATAD2 bromodomain in cancer therapy: current status and future perspectives

Tincy Biju & Parasuraman Pavadai et al. · 2025-05-05

4Citations
TL;DR

Investigation into the function of ATAD2 in oncogenesis and its interactions may offer fresh approaches to creating cancer treatment plans, and potential monoclonal antibodies, RNA-based therapies, and small chemical inhibitors are included in the review.

AI-generated by Semantic Scholar

Authors
Tincy Biju, Chidananda Venkatesh, Darshana Ballagere Honnasiddappa, Mallikarjun Sajjan, Nayan Kumar Mahadeva, Basavana Gowda Hosur Dinesh, Bandral Sunil Kumar, Srinivas Ganjipete, Mohankumar Ramar, Selvaraj Kunjiappan, Panneerselvam Theivendren, Sundar Madasamy, Kumarappan Chidambaram, Damodar Nayak Ammunje, Parasuraman Pavadai